You are here

MIDI, INC.

Company Information
Address
MIDI, INC. 125 SANDY DR
NEWARK, DE 19713
United States



Information

UEI: S9JSJFKH4BZ3

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Authentication quantitation and detection of adulteration in botanical dietary supplements using an automated chemometric platform

    Amount: $148,641.00

    Abstract The objective of this SBIR Phase I proposal is to test the feasibility for development of an automated platform that can perform the followingIdentify botanical components of dietary suppleme ...

    SBIRPhase I2018Department of Health and Human Services Food and Drug Administration
  2. Prevention of Clostridium difficile-associated disease

    Amount: $99,156.00

    DESCRIPTION (provided by applicant): Clostridium difficile-associated disease (CDAD) is a hospital-acquired problem following routine antibiotic treatment. Its impact may exceed that of any other noso ...

    SBIRPhase I2008Department of Health and Human Services National Institutes of Health
  3. Rapid Susceptibility Testing of MDR M. tuberculosis- Phase II

    Amount: $765,957.00

    DESCRIPTION (provided by applicant): The long-term objective of this project is the development of a system based on high performance liquid chromatography (HPLC) for rapid and accurate antibiotic sus ...

    SBIRPhase II2006Department of Health and Human Services National Institutes of Health
  4. Rapid Susceptibility Testing of MDR M. tuberculosis

    Amount: $97,000.00

    DESCRIPTION (provided by applicant): This Phase I research will test the feasibility of using mycolic acid analysis as a very rapid test for drug susceptibility of Mycobacterium tuberculosis. The sig ...

    SBIRPhase I2005Department of Health and Human Services National Institutes of Health
  5. IDENTIFICATION OF BACTERIA DIRECT FROM BLOOD CULTURE

    Amount: $0.00

    DESCRIPTION (Verbatim from Applicant's Abstract):Rapid identification of bacteria direct from a blood culture bottle would speed up patient treatment and recovery, thereby also gre ...

    SBIRPhase I2001Department of Health and Human Services National Institutes of Health
  6. IDENTIFICATION OF BACTERIA DIRECT FROM BLOOD CULTURE

    Amount: $317,465.00

    DESCRIPTION (Verbatim from Applicant's Abstract):Rapid identification of bacteria direct from a blood culture bottle would speed up patient treatment and recovery, thereby also gre ...

    SBIRPhase II2001Department of Health and Human Services National Institutes of Health
  7. Nosocomial infections: Automated typing and data mining

    Amount: $97,560.00

    DESCRIPTION (provided by applicant): Nosocomial infections cause about 90,000 deaths annually in the U.S. and have an associated medical care cost of about 3.5 billion dollars. Despite b ...

    SBIRPhase I2001Department of Health and Human Services National Institutes of Health
  8. N/A

    Amount: $529,855.00

    N/A

    SBIRPhase II1999Department of Health and Human Services
  9. IDENTIFICATION OF BACTERIA DIRECT FROM BLOOD CULTURE

    Amount: $94,474.00

    Not Available There is a need for a fundamentally sound and experimentally validated methodology and software for life prediction for ceramic matrix composite (CMC) propulsion system components and a ...

    SBIRPhase I1999Department of Health and Human Services
  10. RAPID INEXPENSIVE ASSAY FOR TB AND OTHER MYCOBACTERIA

    Amount: $94,964.00

    N/A

    SBIRPhase I1997Department of Health and Human Services
US Flag An Official Website of the United States Government